Market revenue in 2023 | USD 26.0 million |
Market revenue in 2030 | USD 51.5 million |
Growth rate | 10.3% (CAGR from 2023 to 2030) |
Largest segment | Infectious diseases |
Fastest growing segment | Infectious Diseases |
Historical data | 2021 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Infectious Diseases |
Key market players worldwide | Danaher Corp, Kaneka Corp, TriLink BioTechnologies, Apex Biotechnology, BioNTech SE ADR, Lonza Group Ltd, Nunn’s Home Medical Equipment, EQT Corp, Catalent Inc, Samsung Electronics Co Ltd, Biomay AG, Indication, eTheRNA immunotherapies, BioCina |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mrna therapeutics contract development & manufacturing market will help companies and investors design strategic landscapes.
Infectious diseases was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the UAE mrna therapeutics contract development & manufacturing market based on infectious diseases covering the revenue growth of each sub-segment from 2021 to 2030.
The UAE mRNA CDMO market is fueled by the rising number of clinical trial facilities and CDMOs. In addition, it is expected to be driven by the growing demand for pharmaceuticals & CDMOs and the rising adoption of mRNA therapeutics.
These factors are expected to improve the market demand in the country. For instance, in March 2022, the Andrews Labor Government and the Department of Health - Abu Dhabi signed a Memorandum of Understanding (MoU) to discover various opportunities in sharing mRNA research.
This partnership was expected to enable the exchange of RNA industry development strategies and the joint development of RNA-related therapeutics. mRNA Victoria and the Labor Government would continue developing the mRNA and RNA sector in Asia Pacific & Australia by supporting the preclinical & clinical medical research, supply chain development, clinical trials, commercialization, and manufacturing.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE mrna therapeutics contract development & manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into UAE mrna therapeutics contract development & manufacturing market from 2021 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account